Medical information Clinical review pending

Genetic Testing

TSPAN7 Gene Mental Retardation X-Linked Type 58 Genetic Test

Genetic test using Next-Generation Sequencing (NGS) to detect mutations in the TSPAN7 gene, associated with X-linked mental retardation. Helps identify genetic causes of neurological disorders.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Blood sample (EDTA tube) or extracted DNA. Confirm specific requirements with the laboratory before sample collection.
Results: Confirm with the laboratory before booking.
Preparation: No specific patient preparation is required. A detailed clinical history and family history (pedigree chart if possible) are highly recommended to aid interpretation. Genetic counseling is advised.

Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the TSPAN7 Gene Mental Retardation X-Linked Type 58 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Individuals with symptoms of mental retardation or developmental delays.
✓Patients with a family history of X-linked intellectual disability.
✓Individuals referred by a neurologist or genetic counselor.
✓Diagnosis confirmation for suspected X-linked mental retardation Type 58.

In plain language

What this test helps you understand

This test helps identify specific genetic mutations in the TSPAN7 gene that may be responsible for developmental delays and intellectual disabilities. Identifying these mutations can aid in confirming a diagnosis, understanding the underlying cause of a condition, and guiding appropriate medical management and genetic counseling.

The TSPAN7 Gene Mental Retardation X-Linked Type 58 NGS Genetic DNA Test is a specialized genetic analysis designed to identify mutations within the TSPAN7 gene. Variations in this gene are linked to certain neurological conditions, including developmental delays and intellectual disabilities. This test utilizes advanced Next-Generation Sequencing (NGS) technology for a detailed examination of the genetic material. Understanding the genetic basis of these conditions is crucial for accurate diagnosis, appropriate management, and informed family planning. This test is particularly relevant for individuals presenting with symptoms suggestive of X-linked neurological disorders or those with a family history of such conditions. Confirm with the laboratory before booking.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required. A detailed clinical history and family history (pedigree chart if possible) are highly recommended to aid interpretation. Genetic counseling is advised.

SampleBlood sample (EDTA tube) or extracted DNA. Confirm specific requirements with the laboratory before sample collection.

MethodologyNext-Generation Sequencing (NGS) is used to analyze the TSPAN7 gene for specific mutations.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test specifically analyzes the TSPAN7 gene. It does not detect mutations in other genes that may cause similar symptoms. Results must be interpreted in the context of the patient's clinical presentation and family history. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

The TSPAN7 gene provides instructions for making a protein involved in cell communication and development, particularly in the brain. Mutations in this gene are linked to certain neurological conditions.

This test is recommended for individuals showing signs of developmental delays or intellectual disability, especially if there is a family history of X-linked disorders, or if referred by a specialist.

A blood sample is typically required. The laboratory can provide guidance on collection procedures, and home sample collection may be available. Confirm with the laboratory before booking.

Turnaround time varies. Please contact the laboratory directly for the current estimated timeframe.

Results will be interpreted by genetic specialists. They will explain the findings and their implications, often in consultation with the referring physician. Genetic counseling is recommended.

Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp